Cervical Cancer Screening

Quality Payment Program >> Quality Measures >> Cervical Cancer Screening (CMS 124v5)

Under MIPS, eligible clinicians will be required to report up to 6 quality measures, including at least one outcome measure or high-priority measure, for a minimum of 90 days during the 2017 performance year. Practice Fusion currently supports 23 eCQMs that can be reported for MIPS for the 2017 performance year.

Numerator: Women with one or more screenings for cervical cancer. Appropriate screenings are defined by any one of the following criteria:

Cervical cytology performed during the measurement period or the two years prior to the measurement period for women who are at least 21 years old at the time of the test.

Cervical cytology/human papillomavirus (HPV) co-testing performed during the measurement period or the four years prior to the measurement period for women who are at least 30 years old at the time of the test.

Denominator: Women 23-64 years of age with an eligible visit (defined in Table 1) during the measurement period.

• Denominator Exclusions: Women who had a hysterectomy with no residual cervix.
• Denominator Exceptions: None

Performance Benchmark for MIPS: 69.00%
For further benchmarks and details on how this measure will be scored within the Quality performance category of MIPS, please click here.